Meeting Coverage

AAAAI

American Academy of Allergy Asthma & Immunology

Very Low-Dose OIT Shows Efficacy for Peanut-Allergic Kids

Plus, for sesame-allergic kids, oral desensitization effective with crushed sesame seeds, tahini

AAAAI over a photo of Henry B. Gonzalez convention center in San Antonio, Texas.

Latest AAAAI Meetings

Stress-Related COVID Vaccine Reactions May Mimic Anaphylaxis

ISRR may contribute to elevated rate of "allergic" reactions, small study suggests

March 1, 2023
Sustained Benefits With Mepolizumab in Severe Eosinophilic Asthma

A fifth of patients no longer needed oral steroids 2 years after starting biologic

March 1, 2023
Peanut-Allergic Kids With Other Food Allergies, Eczema See Responses With EPIT

Will epicutaneous immunotherapy be a lower-burden alternative to oral immunotherapy?

February 28, 2023
Biologics for Asthma: Who Gets Them and Who Uses Them?

Single-center study finds sluggish prescriptions, but patient-level barriers are also at work

February 28, 2023
Investigational Biologic Shows Efficacy for HAE Prophylaxis

Once-a-month drug had a big impact on attack rates

February 27, 2023
Real-World Data Confirm Early Peanut Feeding Benefit for High-Risk Infants

But caregivers reported that following the feeding protocol was not always easy

February 27, 2023
Mepolizumab Reduces Need for Oral Steroids in Severe Asthma

Some adults on the IL-5 antibody were able to stop taking systemic steroids

March 2, 2022
Docs Debate Home Spirometry

Is it ready for prime time or is it just a toy with possible serious consequences?

March 2, 2022
Does One Mab Come Out on Top for Boosting Lung Function in Asthma?

Dupilumab edges out other biologics, but differences were small in indirection comparison

March 1, 2022
Mepolizumab Cuts Asthma Flare-Ups in Disadvantaged Kids

Black and Hispanic children living in urban settings benefited from biologic therapy

March 1, 2022
Many Severe Asthma Patients Achieve Remission on Biologics

Year-long freedom from exacerbations without steroids reported in real-world study

February 28, 2022
Tezepelumab Benefits Asthma Patients Year-Round

Biologic consistently reduced the annualized asthma exacerbation rate

February 28, 2022
Medical Approach May Work in Nasal Polyps With Asthma

Omalizumab improves polyp symptom scores with low recurrence rate

February 28, 2022
Glimpses of Hope for Lebrikizumab in Asthma

Subgroup targeting may hold promise for biologic

February 28, 2022